Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Avelumab Maintenance in Advanced Urothelial Carcinoma: Biomarker Analysis of the Phase 3 JAVELIN Bladder 100 TrialNat. Med. 2021 Dec 01;27(12)2200-2211, T Powles, SS Sridhar, Y Loriot, J Bellmunt, XJ Mu, KA Ching, J Pu, CN Sternberg, DP Petrylak, R Tambaro, LM Dourthe, C Alvarez-Fernandez, M Aarts, A di Pietro, P Grivas, CB Davis
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.